Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 3 13Phase 1 10Phase 1/2 7Phase NA 6Phase 2/3 5Phase 4 3Phase EARLY_PHASE1 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 5Gastrointestinal 5Thoracic 4Breast 4Lymphoid 3Plasma cell 1Other solid neoplasm 1Head & Neck 1Genitourinary 1

Conditions

Lymphoma, Non-Hodgkin 2Lymphoma, Extranodal NK-T-Cell 1

Interventions

Cyclophosphamide 27Vincristine 24Dexamethasone 22Rituximab 21Methotrexate 21Cytarabine 21Mercaptopurine 16Doxorubicin 15Etoposide 13Asparaginase 13Daunorubicin 12Prednisone 10Prednisolone 10Granulocyte Colony-Stimulating Factor 10Ifosfamide 8Idarubicin 8fludarabine 7pegylated granulocyte colony-stimulating factor 6Thioguanine 6Teniposide 6Vindesine 5Brentuximab Vedotin 5ibrutinib 4fludarabine phosphate 4Stem Cell Transplantation 4Gemcitabine 4Cisplatin 4Aprepitant 4zanubrutinib 3prednylidene 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Drug Therapy × Lymphoid × Clear all
NCT04134247 2019-10-22

Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL

Shandong Provincial Hospital

Phase 4 Unknown
120 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT02782845 2016-11-21

An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)

Hoffmann-La Roche

Phase 4 Completed
53 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT01501136 2015-07-17

CTTNKTL-I/II

Zhengzhou University

Phase 4 Unknown
200 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡